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OBJECTIVES The purpose of this research was to evaluate the significance of heart rate response to
dobutamine and the assessment of left ventricular (LV) function during risk stratification of
patients undergoing dobutamine stress myocardial perfusion imaging (DSMPI).
BACKGROUND Dobutamine stress myocardial perfusion imaging has been shown to effectively risk stratify
highly selected patients. However, based on perfusion alone, patients with normal and
abnormal tests have twice the risk as comparable patients with exercise testing. The added
value of assessment of LV function and the heart rate response to dobutamine in risk
stratification of these patients is unknown.
METHODS Follow-up information (cardiac death or non-fatal myocardial infarction) was obtained on
1,367 consecutive patients who underwent DSMPI due to inability to perform adequate
exercise and contraindications to vasodilators. Perfusion images were interpreted using a
17-segment model. Abnormal perfusion and function were defined as: summed stress score
4 and ejection fraction 50%, respectively.
RESULTS Annualized event rates (AERs) were related to the extent/severity of perfusion defects and
worsening LV function. A three-risk category model was constructed from combined
assessment of perfusion and function, with AERs of 2.4% (both normal), 5.8% (discordant),
and 11.3% (both abnormal); p  0.001. Stress electrocardiogram (ECG) data added
incremental value to myocardial perfusion alone but not to combined assessment of perfusion
and function. Importantly, inability to achieve 85% of mean predicted heart rate was
associated with worse outcomes and was an independent predictor of cardiac events. For
patients in whom perfusion, function, and stress ECG response were normal, inability to
achieve target heart rate was associated with significantly higher AER (1.5% vs. 3.4%,
respectively, p  0.021).
CONCLUSIONS In highly selected patients undergoing DSMPI, assessment of perfusion and function is effective
in risk stratification. The stress ECG and heart rate response to dobutamine have prognostic
value and should be incorporated into image interpretation so as to maximize risk
stratification. (J Am Coll Cardiol 2006;47:781–8) © 2006 by the American College of
ublished by Elsevier Inc. doi:10.1016/j.jacc.2005.09.059Cardiology Foundation
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uharmacologic stress myocardial perfusion imaging (MPI)
s an excellent alternative for the evaluation of patients with
nown or suspected coronary artery disease (CAD) who are
nable to perform adequate exercise. In general, vasodilator
tress is the first choice while dobutamine is reserved for
atients with contraindications. While the diagnostic accu-
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niversity School of Medicine, Providence, Rhode Island. This study was partially
upported by a research grant from Bristol-Myers Squibb Medical Imaging (Billerica,
assachusetts). Dr. Heller receives research support and honoraria from Bristol-
yers Squibb.s
Manuscript received March 10, 2005; revised manuscript received August 11, 2005,
ccepted September 19, 2005.acy of dobutamine stress MPI (DSMPI) is similar to other
tress modalities (1–4), there are few data regarding risk
tratification (5–8). Previous studies, from three centers,
ave employed DSMPI in different patient populations. Of
hose, only the study by Calnon et al. (8) evaluated patients
onsistent with the current practice in the U.S., namely
hose unable to exercise and having contraindications to vaso-
ilator stress. In contrast to studies in unselected populations
5–7), Calnon et al. (8) found two-fold higher event rates in
atients with either normal or abnormal perfusion than
xercise stress.
The reason for the higher cardiac event rate in patients
ndergoing DSMPI is unclear, although several studies have
uggested inability to exercise is an independent marker of poor
o
s
f
s
(
o
D
r
i
D
g
o
r
c
g
s
M
P
u
i
f
H
t
w
k
m
E
w
e
t
(
b
e
f
T
r
D
o
i
m
e
I
t
h
p
t
J
p
e
p
f
a
I
o
S
(
T
e
p
i
l
c
t
n
o
r
N
u
I
p
o
h
v
S
o
s
p
1
a
(
a
t
t
B
n
i
p
r
a
8
L
a
G
v
782 Navare et al. JACC Vol. 47, No. 4, 2006
Risk Stratification, Dobutamine Stress Imaging February 21, 2006:781–8utcome (9,10). Efforts to maximize risk stratification with
tress MPI have been directed towards incorporation of
unctional data from electrocardiogram (ECG)-gated
ingle-photon emission computed tomography (SPECT)
11,12) as well the ECG response to stress (8,13). More-
ver, identification of the presence and extent of CAD with
SMPI may require, at least in part, an adequate heart rate
esponse (14). To our knowledge, there are no data exam-
ning either the importance of heart rate response with
SMPI or incorporation of functional data from ECG-
ated SPECT in risk stratification. Therefore, the purpose
f this study was to examine the prognostic value of heart
ate and ECG response to dobutamine and the utility of
ombined assessment of perfusion and function by ECG-
ated SPECT imaging for risk stratification of a highly
elected population.
ETHODS
atient selection. A total of 1,429 consecutive patients
nderwent dobutamine Tc-99m sestamibi SPECT imag-
ng between October 1995 to November 2002, at Hart-
ord Hospital, Hartford, Connecticut, or Rhode Island
ospital, Providence, Rhode Island, for clinical indica-
ions. The main indications were symptoms in patients
ith suspected CAD (76%), symptoms in patients with
nown CAD (11%), pre-operative evaluation (5%), and
iscellaneous (congestive heart failure [CHF], abnormal
CG, and so on) in 8%. At both institutions, DSMPI
as reserved for patients unable to perform adequate
xercise and with contraindications to vasodilators. Of
hose patients, 62 underwent coronary revascularization
percutaneous coronary intervention or coronary artery
ypass grafting) within 90 days of DSMPI and were
xcluded from analysis. The remaining 1,367 patients
ormed the study group (mean age, 67.9  12.4 years).
he study protocol was approved by the institutional
eview board committees of both institutions.
obutamine stress test. All patients underwent either a
ne- or two-day rest and stress Tc-99m sestamibi SPECT
Abbreviations and Acronyms
CAD  coronary artery disease
CHF  congestive heart failure
DSMPI  dobutamine stress myocardial perfusion
imaging
ECG  electrocardiographic/electrocardiogram
LV  left ventricle or left ventricular
LVEF  left ventricular ejection fraction
MPHR  maximum predicted heart rate
MPI  myocardial perfusion imaging
SDS  summed difference score
SPECT  single-photon emission computed tomography
SRS  summed rest score
SSS  summed stress score
THR  target heart ratemaging protocol. Dobutamine was administered in incre- fental doses, beginning with 5 g/kg/min and increased
very 3 min through stages at 10, 20, 30, and 40 g/kg/min.
ntravenous atropine and/or arm exercise was added if the
arget heart rate (THR) (85% of the maximum predicted
eart rate [MPHR]) was not achieved at the peak dose. A
ositive ECG response was defined as ST-segment eleva-
ion or ST-segment depression 0.1 mV at 80 ms after the
point. For patients undergoing a two-day stress/rest
rotocol, 25 to 40 mCi of Tc-99m sestamibi was used for
ach SPECT study, while for patients undergoing a one-day
rotocol, 10 to 15 mCi of Tc-99m sestamibi was injected
or rest and 30 to 45 mCi for stress imaging; SPECT
cquisition was begun 30 to 60 min after stress injection.
mage acquisition. All images were acquired using dual-
r single-headed SPECT gamma cameras (Phillips Medical
ystems, Milpitas, California). Sixty-four projections
25 s/projection at rest; 20 s/projection at stress) with
c-99m sestamibi were obtained in a 180° semicircular arc
xtending from the 45° right anterior oblique to the 45° left
osterior oblique position. All projection images were stored
n a 64  64  16 matrix. Images were processed using a
ow-pass Butterworth filter with a frequency cutoff of 0.66
ycles/pixel and an order of 5 for reconstruction of the
ransaxial slices to a thickness of 6.6 mm. Azimuthal defi-
ition (from apex to base or anterior to posterior) was
btained from the mid-transverse and sagittal slices for
econstruction of the short-axis and vertical long-axis slices.
o preprocessing filtration or attenuation correction was
sed.
mage interpretation. All SPECT images were inter-
reted by a consensus of three experienced nuclear cardiol-
gists without knowledge of patient identity or clinical
istory. For assessment of myocardial perfusion, the left
entricle (LV) was divided according to the American
ociety of Nuclear Cardiology/American College of Cardi-
logy/American Heart Association recommended 17-
egment model (15). All segments were scored for regional
erfusion using a 5-point scale (0 normal photon activity,
 mild, 2  moderate, 3  severe reduction in photon
ctivity, 4  absent photon activity). A summed stress score
SSS) and summed rest score (SRS) were obtained by
dding the scores of all segments at stress and rest, respec-
ively. A summed difference score (SDS) was calculated as
he difference between the SSS and SRS (SSS  SRS).
ased on the SSS, perfusion images were classified as
ormal (score 0 to 3) or abnormal (score 4). Abnormal
mages were further classified based on SDS: either with a
redominantly fixed defect for a score of 2 or with a
eversible defect for a score of 2. In addition patients were
lso stratified as low- (SSS 0 to 3), intermediate- (SSS 4 to
), or high-risk (SSS 8) for subsequent cardiac events.
eft ventricular ejection fraction (LVEF) was obtained
utomatically from the QGS software as described by
ermano et al. (16) and confirmed visually for accuracy. Left
entricular function was considered preserved for ejection
raction 50% or impaired for LVEF 50%. Impaired LV
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February 21, 2006:781–8 Risk Stratification, Dobutamine Stress Imagingunction was further classified as mild to moderately impaired
LVEF 30% to 49%), or severely impaired (30%).
ollow-up. Individuals blinded to the patient’s test results
erformed patient follow-up using scripted telephone inter-
iews and mailed questionnaires. Events were defined as
ardiac death or non-fatal myocardial infarction and were
onfirmed by reviews of death certificates, hospital charts,
hysician records, and appropriate laboratory test results.
tatistical analysis. Patient demographics were expressed
s mean  SD or as proportions. Intergroup comparisons
ere made using a two-tailed unpaired Student t test for
ontinuous variables and the chi-square test for discrete
ariables. All p values 0.05 were considered significant.
nivariate analyses of hard cardiac event-free (cardiac
eath, non-fatal myocardial infarction) survival curves were
erformed using the Kaplan-Meier procedure and com-
ared by means of the log-rank test. Significant variables
valuated in the univariate analysis were entered into a Cox
roportional hazards regression model. A backward step-
ise selection procedure, with variable removal based on the
ald statistic probability, was performed, with variables
ntered into the model with a p  0.10 and removal with a
 0.05.
ESULTS
obutamine stress data. The THR (85% of maximum
redicted for age) was not reached in 445 (32.5%) patients.
he reasons for termination of stress tests in these patients
ere end of protocol (i.e., after maximum doses of dobut-
mine and atropine were given) in 75%, worsening symp-
able 1. Patient Demographics and Stress Variables
Cardiac
Events
No Cardiac
Events p Value
125 1,242
ge 73.25  10.99 67.60  12.16 0.002
ender (male) 60 (48%) 704 (56.7%) 0.005
ypertension 80 (64%) 717 (57.7%) NS
iabetes 55 (44%) 401 (32.3%) 0.038
istory of MI 51 (40.8%) 203 (16.3%) 0.00
istory of CHF 30 (24%) 86 (7.0%) 0.000
rior CABG/PCI 47 (37.6%) 190 (15.3%) 0.00
ypercholesterol 61 (48.8%) 463 (37.3%) NS
moking 56 (44.8%) 513 (41.3%) NS
amily history 37 (30.1%) 341 (27.5%) NS
edications
eta-blockers 43 (34.4%) 322 (26.0%) NS
CE 31 (24.8%) 309 (25.0%) NS
ipid lowering 42 (33.6%) 300 (24.1%) NS
SA 41 (32.8%) 407 (32.8%) NS
obutamine stress
variables
85% of MPHR 78 (62.4%) 844 (68.0%) 0.013
Positive ECG 82 (65.6%) 544 (44.0%) 0.000
CE  angiotensin-converting enzyme; ASA  acetylsalicylic acid; CABG 
oronary artery bypass grafting; CHF  congestive heart failure; ECG  electrocar-
iogram; MI  myocardial infarction; MPHR  maximum predicted heart rate;
CI  percutaneous coronary intervention.oms in 16%, hypotension in 4%, worsening ECG changes
E
en 3%, and arrhythmias in 2%. The prior use of beta-
lockers was significantly related to the inability to reach the
HR (42% of patients not reaching THR received a
eta-blocker drug vs. 23% of patients who reached THR,
 0.01). Dobutamine stress MPI was considered non-
iagnostic for patients who did not achieve THR (in
bsence of symptoms or ECG changes), but had normal
erfusion images.
ollow-up. The mean follow-up period was 25  15.2
onths and was complete in 97.8% of the 1,367 patients.
here were 78 cardiac deaths and 47 non-fatal myocardial
nfarctions in the follow-up period. Patients who had
ardiac events were older, more likely to be women, and
ore likely to have diabetes, prior history of myocardial
nfarction, CHF, and prior revascularization as compared to
hose who did not have events (Table 1). Otherwise, the two
roups were comparable for coronary risk factors and use of
ardiovascular medications.
isk stratification according to perfusion imaging
esults. Images were interpreted as normal in 852 patients
62.3%) and abnormal in 515 patients (37.7%) (Table 2).
he annualized hard cardiac event (cardiac death or non-
atal myocardial infarction) rate for patients with normal
erfusion images was significantly lower (2.5%) than for
hose with abnormal images (7.6%, p  0.01, odds ratio 
.3 [95% confidence interval, 2.2 to 4.9]). The annual rates
or both cardiac death and myocardial infarction increased
n relation to the severity of the perfusion abnormality
Fig. 1). When considered in relation to severity of ischemia
SDS), the annualized rates of cardiac death were 2.6%,
.4%, and 5.7% (p  0.05; 5.7% vs. 2.6% and 2.4%) and
hose of myocardial infarction were 1.8%, 3.4%, and 3.7%
p  0.05; 1.8% vs. 3.4% and 3.7%) in patients with SDS
cores of 0 to 2, 3 to 6, and 6, respectively. Thus, the
resence of any ischemia was associated with an increased
isk of myocardial infarction, while only severe ischemia was
ssociated with an increased risk of cardiac death.
rognostic value of LV functional assessment by ECG-
ated SPECT. Electrocardiogram-gated SPECT imaging
as performed in 1,205 patients (88%). Left ventricular
able 2. SPECT Data
Cardiac
Events
No Cardiac
Events p Value
125 1,242
PECT (clinical)
Normal 39 (31.2%) 813 (65.4%) 0.001
Reversible defects 43 (34.4%) 210 (17.0%) 0.006
Fixed defects 43 (34.4%) 219 (17.6%) 0.062
lobal scores
SSS 7.7  7.7 3.8  6.2 0.0001
SDS 2.0  3.5 1.2  2.7 0.002
ated SPECT
EF (mean) 46.3  16.5 56  13.5 0.0001
EF 50% (%) 50% 22% 0.0001F  ejection fraction; SDS  summed difference score; SPECT  single-photon
mission computed tomography; SSS  summed stress score.
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Risk Stratification, Dobutamine Stress Imaging February 21, 2006:781–8unction was inversely related to annual cardiac event rates,
ith highest rates observed in those with lowest ejection
ractions (annualized rates of 3.0%, 8.3%, and 13.5% for
atients with normal LV function [n  905], mild to
oderately impaired LV function [n  223], and severely
mpaired LV function [n  77], respectively). Rates of both
ardiac death and myocardial infarction increased with
orsening systolic dysfunction; however, there was a dis-
roportionately greater risk of cardiac death over myocardial
nfarction in patients with severely depressed LV function
ejection fraction 30%) (Fig. 2).
Combining perfusion and functional data categorized
atients into three risk categories: patients with normal
igure 1. Rates of cardiac death (CD) (open bars) and non-fatal myocardia
he number of patients in each category is given in parentheses; the num
enote the actual number of events. The data demonstrate increasing ann
igure 2. Rates of cardiac death (CD) (open bars) and myocardial infarcti
s measured by ejection fraction (EF) by gated single-photon emission computed
sharp increase in CD with severely depressed LV function.erfusion and normal function (n  702) had the best
rognosis; those with abnormal perfusion and abnormal
unction (n  203) had significantly lower cardiac event-
ree survival; while those with discordant perfusion and
unction (n  300) had an intermediate prognosis (Fig. 3).
nnualized hard event rates for the three risk categories
ere 2.4%, 11.3%, and 5.8%, respectively.
alue of dobutamine-induced ECG changes. Informa-
ion regarding the ST-segment ECG response to dobut-
mine stress was available in 1,228 (89.8%) of the patients,
egardless of the level of heart rate achieved. Of these, 744
60%) patients had normal stress ECG, 406 (33%) patients
ad a positive ECG response, and 78 (7%) patients had an
ction (MI) (solid bars) in relation to the severity of perfusion abnormality.
bove the bars represent the event rates, and the numbers within the bars
d CD and MI rates with increasing summed stress score (SSS).
I) (solid bars) plotted according to left ventricular (LV) systolic functionl infaron (M
tomography. Cardiac events increased with worsening LV function with
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February 21, 2006:781–8 Risk Stratification, Dobutamine Stress Imagingnconclusive response. When used in combination with
erfusion data, patients with a normal ECG response and
ormal perfusion (n  482) had the most favorable prog-
osis, while those with an abnormal ECG response and
bnormal perfusion (n  101) had the least favorable
rognosis (Fig. 4). Patients with discordant ECG and
erfusion (n  645) results had an intermediate progno-
is, significantly different from the other two categories
p  0.01).
Thus, stress ECG data had incremental value over perfusion
lone. However, stress ECG data did not provide any addi-
ional risk stratification when added to the combined assess-
ent of perfusion and function by gated-SPECT. In patients
ith both normal perfusion and function, the ECG re-
ponse did not further differentiate the risk (cardiac event
igure 3. Kaplan-Meier analysis demonstrating cardiac event-free survival
atients at each time interval is given in parenthesis.igure 4. Kaplan-Meier analysis showing incremental prognostic value of electr
he number of patients at each time interval is given in parenthesis.ates 3.5% with positive ECG vs. 2.2% with negative ECG,
 NS) nor did it add to the evaluation of patients with
bnormal perfusion and function (cardiac event rates 11.9%
ith positive ECG vs. 11.2% with negative ECG, p NS).
mportance of heart rate response with dobutamine
tress. An important diagnostic issue with DSMPI is the
chievement of THR, such that failure to achieve this
andmark may underestimate the severity of CAD (14). To
valuate its importance on risk stratification, patients were
ubclassified according to whether THR was reached. Pa-
ients who did not reach the THR had higher event rates
han patients who achieved the THR (Fig. 5). Importantly,
n the low-risk group (patients with normal perfusion,
ormal LV function, and negative ECG response), it had
ncremental value for risk stratification (annualized event
rding to combined assessment of perfusion and function. The number ofocardiogram response to dobutamine over perfusion for risk stratification.
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Risk Stratification, Dobutamine Stress Imaging February 21, 2006:781–8ates 1.5% for those achieving THR [n  338] vs. 3.4% for
atients not reaching THR [n  144], p  0.021).
ariables associated with cardiac events. UNIVARIATE
NALYSIS. The clinical univariate predictors associated with
ardiac events were age; female gender; diabetes; and a
istory of myocardial infarction, CHF, or revascularization
either coronary artery bypass grafting or percutaneous
oronary intervention). Of the stress variables, inability to
each 85% of MPHR and an abnormal ECG response to
obutamine stress were related to increased rate of cardiac
vents (Table 1). With respect to nuclear variables, the
resence of reversible perfusion defects and an ejection
raction50% were associated with a significantly increased
ardiac event rate (Table 2).
ULTIVARIABLE ANALYSIS: COX PROPORTIONAL HAZARDS.
linical variables significantly related to cardiac events were
ntered into a model for multivariable analysis by Cox
roportional hazards method (Table 3). Advanced age,
istory of CHF, inability to achieve 85% of MPHR, and the
resence of either fixed or reversible defects were all inde-
endent predictors of cardiac events. When analyzed sepa-
ately, a reversible defect was a significant predictor of
yocardial infarction but not cardiac death, whereas a fixed
efect predicted both myocardial infarction and cardiac
eath. Conversely, an impaired LV function was a signifi-
ant predictor of cardiac death.
ISCUSSION
n the U.S., DSMPI is generally reserved for patients unable
o exercise adequately and who have contraindications to
asodilator stress. Few studies are available to describe its
igure 5. Importance of achieving target heart rate in response to dob
lectrocardiogram (ECG) response, normal perfusion and function; the h
bnormal perfusion and function, while intermediate-risk category is rep
eart rate.alue in risk stratification of this patient population; partic-

rlarly lacking are the data incorporating both myocardial
erfusion and function. Our study demonstrates that
SMPI can successfully provide risk stratification alone and
n combination with functional data, based upon perfusion
cores and the severity of LV dysfunction. While the ECG
esponse to dobutamine is useful, it does not add to the risk
tratification provided by combined assessment of perfusion
nd function. However, achieving the THR is of impor-
ance in risk stratification of these patients. As with previous
tudies of DSMPI, cardiac event rates were higher than
hose reported in studies of exercise stress MPI, and it is not
ossible to define an absolute low-risk category (annualized
ardiac event rate of 1%), even using a combination of
tress testing and ECG-gated SPECT variables.
isk stratification with DSMPI. Dobutamine stress MPI
as been used as an alternative pharmacologic stress agent
or several years with a high diagnostic accuracy. In an
nselected population, risk stratification with DSMPI is
omparable to that with exercise MPI (5,6); however, in a
ighly selected population (as is the current practice in the
.S.), there are important differences as compared to
ne infusion. Low-risk category is represented by patients with normal
sk category is represented by patients with abnormal ECG response and
ted by patients with either abnormality. MPHR  maximum predicted
able 3. Cox Proportional Hazards Regression Model
Multivariate Analysis)
Variables MI CD CD and/or MI
ge 77 yrs 3.56 (1.41–8.89) 2.20 (1.03–4.72) 2.24 (1.23–4.08)
istory of CHF — 2.67 (1.47–4.85) 2.01 (1.23–3.29)
PHR 85% — 2.03 (1.22–3.30) 1.15 (1.01–2.26)
D 2.90 (1.40–6.01) 2.47 (1.21–5.05) 2.89 (1.72–4.87)
D 2.65 (1.40–5.01) — 1.82 (1.15–2.88)
F 50% — 2.01 (1.06–3.86) —
umbers in parentheses denote 95% confidence intervals.
CD  cardiac death; CHF  congestive heart failure; EF  ejection fraction; FDutami
igh-rifixed defect; MI  myocardial infarction; MPHR  maximum predicted heart
ate; RD  reversible defect.
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February 21, 2006:781–8 Risk Stratification, Dobutamine Stress Imagingxercise MPI. Calnon et al. (8) evaluated the prognostic role
f DSMPI in a representative, highly selected population
nd showed a higher level of risk. In that study, annualized
ardiac event rates in patients who underwent DSMPI were
pproximately two-fold higher than in those referred for
xercise MPI at the same institution. Using a similar patient
opulation, we also observed relatively high annual cardiac
vent rates in patients with normal (2.5%) or abnormal
7.6%) perfusion, which are comparable to those reported by
alnon et al. (8). Furthermore, for DSMPI, similar to
xercise and vasodilator stress MPI, we were able to dem-
nstrate the added prognostic value of LV function beyond
erfusion data alone. Our study also examined cardiac death
nd myocardial infarction as separate end points and demon-
trated a relationship between both outcomes and the extent/
everity of dobutamine-stress-induced perfusion abnormal-
ties and the incremental prognostic value of assessment of
V function by gated SPECT. In addition, we identified
he importance of achieving the THR while performing risk
tratification with DSMPI. Thus, effective risk stratification
s possible with DSMPI for either cardiac death or myo-
ardial infarction, and our study supports the use of this
tress modality for decision making, similar to that de-
cribed with exercise MPI (17).
isk stratification with combined assessment of myocar-
ial perfusion and function. Previous studies have shown
hat LVEF as measured by radionuclide angiography is a
owerful predictor of cardiac death, particularly after acute
yocardial infarction (18). Sharir et al. (11) extended those
bservations using post-stress LVEF as measured by ECG-
ated SPECT. Those investigators found that LVEF after
xercise or adenosine stress has incremental value over pre-scan
nd perfusion variables in the prediction of cardiac death. To
ur knowledge, no previous study has evaluated the prognostic
alue of LVEF obtained from gated SPECT in patients
eferred for DSMPI. We found that, in patients undergoing
SMPI, future cardiac events, cardiac deaths in particular,
ere directly related to the severity of LV dysfunction. In
ddition, patients with both normal perfusion and function
ad a better prognosis than those with both abnormal
erfusion and function who had a very poor prognosis.
onversely, patients with either abnormal perfusion or
unction had an intermediate prognosis. These findings
upport the use of combined assessment of perfusion and
unction in risk stratification of patients undergoing
SMPI.
rognostic value of ECG response to dobutamine. Elec-
rocardiographic changes indicative of myocardial ischemia
re more common with dobutamine than vasodilator stress
overall incidence 50%). Although dobutamine-stress–
nduced ECG changes are more sensitive (58%) for the
etection of CAD in comparison with vasodilator-stress–
nduced ECG changes, they are less specific (60%) (4).
alnon et al. (8) were the first group to demonstrate that the
CG response to dobutamine stress has an important role
n risk stratification beyond perfusion. Data from our study sonfirm the findings of Calnon et al. (8), pointing out that
tudies with normal perfusion but an abnormal ECG
esponse carry a higher level of risk and should not be
eported as “normal.” This is particularly important when
ssessment of ventricular function is not available.
rognostic value of achieving THR. In our study, inabil-
ty to achieve THR was an independent predictor of cardiac
eath and the combined end point of cardiac death and
yocardial infarction. The inability to achieve THR has
een shown to impair diagnostic accuracy with both exercise
tress MPI (19) and DSMPI (14). To our knowledge, this
s the first study to show the prognostic value of this
mportant stress variable. We found that the concomitant
se of beta-blockers was associated with an inability to
chieve THR during dobutamine stress. Notably, patients
n whom perfusion, function, and stress ECG were all
ormal, but who did not achieve THR with DSMPI, had a
ignificantly higher event rate than those who achieved
HR. Similarly, patients in whom perfusion, function, and
tress ECG were all abnormal, and who failed to achieve
HR, had an extremely poor prognosis. Thus, heart rate
esponse with DSMPI must be considered in risk stratifi-
ation in addition to the ECG response, myocardial perfu-
ion, and functional information, as those who fail to
chieve THR are at greater risk of a cardiac event, probably
ue to underestimation of the presence and extent/severity
f CAD. Discontinuation of beta-blocker therapy before
SMPI may be a consideration, but should be approached
ith caution by clinicians, particularly in patients with
nown CAD.
igher risk of the DSMPI population. In both studies
hat evaluated the role of DSMPI in a highly selected
opulation, the current study and that of Calnon et al. (8),
he annual cardiac event rates with normal perfusion alone
ere 2% per year, implying an intermediate level of risk
ather than low risk. While this has been attributed to the
igher intrinsic cardiac risk of the population studied, it was
nticipated that the addition of functional data would
nable the identification of the low-risk subgroup. However,
n our study, even patients with normal perfusion and
unction had a cardiac event rate of 2.4% per year, an
ntermediate level of risk. Even the addition of ECG data
nly lowered the event rate in patients with normal ECG
esponse, normal perfusion, and normal function to 2.2%.
n our study, the population with the lowest risk was
atients who achieved their THR (85% of mean predicted
eart rate) and had a normal ECG response, normal
erfusion, and normal LV function (an annualized cardiac
vent rate of 1.5%). Yet this is still higher than the
ell-accepted criteria of 1% annual cardiac event rate for
lassifying patients into the absolute low-risk category.
For several reasons, it is our impression that the inability
o identify a truly low-risk subgroup in highly selected
atients undergoing DSMPI is not a failure of the dobut-
mine test to provide effective risk stratification. First,
imilar findings have recently been reported for pharmaco-
l
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tress MPI, patients who underwent pharmacologic stress
ere found to have higher event rates than those who had
ndergone exercise, in the presence of either normal or
bnormal perfusion. The higher event rates seen with
harmacologic stress MPI appeared to be related to the
igher intrinsic cardiac risk of the patient population, rather
hen differences in stressors. Second, when DSMPI has
een used in unselected patients, either as an alternative to
xercise stress or vasodilator stress (5–7), normal perfusion
as associated with excellent outcomes (annualized cardiac
vent rate of 1%). Thus, the higher event rate with
SMPI is most likely related to the overall population risk
ather than issues with the stressor itself.
tudy limitations. Data from this study were acquired
efore the widespread use of attenuation correction tech-
ology at our centers. Though attenuation correction im-
roves the diagnostic accuracy of perfusion imaging, it is not
lear if its use would improve risk stratification. Its use
ould not have reduced the cardiac event rates in patients
ith normal images. The higher event rate on follow-up
ould be a result of progression of coronary disease. How-
ver, our study was not structured to evaluate the progres-
ion of coronary disease in this population. Thus, the
ausality of the higher event rates remains speculative.
onclusions. In highly selected patients referred for do-
utamine stress MPI, effective risk stratification is possible
sing a combination of perfusion and function data obtained
rom ECG-gated SPECT as well as the stress ECG
esponse. Of importance, patients who fail to achieve THR
ith dobutamine stress are at greater risk for future cardiac
vents. Hence, incorporation of each of these stress-testing
ariables with image interpretation is critical, so as to
aximize the risk stratification potential of this non-
nvasive procedure.
ddress for correspondence: Dr. Gary V. Heller, Nuclear Car-
iology Laboratory, Hartford Hospital, 80 Seymour Street, Hart-
ord, Connecticut 06102. E-mail: gheller@harthosp.org.
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